首页> 外文OA文献 >PSY6 Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Where Surgery is Contraindicated in Colombia

【2h】

PSY6 Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Where Surgery is Contraindicated in Colombia

机译：Romiplostim的PSY6成本-效果在难以接受其他治疗的成年脾脏切除患者中作为一线主要免疫血小板减少症（Itp）治疗和在哥伦比亚禁忌手术的成年非脾切除患者中作为二线Itp治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Vargas-Valencia J; Garcia Perlaza J;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study [J] . Tjonnfjord Eirik, Holme Pal Andre, Darne Bernadette, British Journal of Haematology . 2020,第3期

机译：用Rituximab治疗的患者的长期结果作为成人免疫血小板减少症的二线治疗 - RITP研究的随访
2. The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: Use experience at a Spanish university hospital [J] . Marquínez-AlonsoI., Escudero-VilaplanaV., PerníaS., Journal of Clinical Pharmacy and Therapeutics . 2014,第4期

机译：成人和儿童患者使用罗米洛司汀治疗原发性免疫性血小板减少症：在西班牙大学医院的使用经验
3. Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study [J] . Lucchini Elisa, Palandri Francesca, Volpetti Stefano, British Journal of Haematology . 2021,第2期

机译：Eltompagag二线治疗成年患者的原发性免疫血小板减少症试图达到持续缓解的脱离治疗：结果II期，多期，前瞻性研究
4. A Dosimetric Analysis of the Overlapping and Gap Areas Produced by Simulated Set-Up Errors on a Treatment Planning System in a Case of the Cranio-Spinal Irradiation of an Adult Patient [C] . Edis Dedovic, Hasan Osmic, Muhamed Topcagic International Conference on Medical and Biological Engineering . 2020

机译：在成人患者的颅脊照射的情况下，在治疗计划系统中模拟设置误差产生的重叠和间隙区域的剂量分析
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies [O] . David J. Kuter, Adrian Newland, Beng H. Chong, -1

机译：新诊断或持续性免疫性血小板减少症（ITP）长达1年的成年患者和慢性ITP超过1年的成年患者中的Romiplostim：来自已完成romiplostim研究的综合数据的亚组分析
7. PSY27 Cost-Consequence Analysis Comparing Romiplostim to Rituximab in the Treatment of Adult Primary Immune Thrombocytopenia (Itp) in France [O] . Chiche L., Lefrere F., Chulikavit M., 2011

机译：PSY27在法国成人成人免疫性血小板减少症（Itp）治疗中比较Romiplostim和Rituximab的成本-后果分析

PSY6 Cost-Effectiveness of Romiplostim As First-Line Primary Immune Thrombocytopenia (Itp) Treatment in Adult Splenectomised Patients Who are Refractory to Other Treatments and As Second-Line Itp Treatment in Adult Non-Splenectomised Patients Where Surgery is Contraindicated in Colombia

著录项

相似文献

相关主题

期刊订阅